Greenwood Gearhart Inc Danaher Corp Transaction History

Greenwood Gearhart Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$185.1 - $233.13 $120,315 - $151,534	650 New	650 $150,000
Q2 2022 Aug 16, 2022	SELL	$237.11 - $299.66 $333,613 - $421,621	-1,407 Reduced 44.57%	1,750 $444,000
Q1 2021 May 13, 2021	SELL	$212.38 - $245.9 $1,486 - $1,721	-7 Reduced 0.22%	3,157 $711,000
Q4 2020 Feb 16, 2021	BUY	$212.5 - $245.46 $12,112 - $13,991	57 Added 1.83%	3,164 $703,000
Q3 2020 Nov 13, 2020	SELL	$177.16 - $215.33 $1,062 - $1,291	-6 Reduced 0.19%	3,107 $669,000
Q4 2019 Jan 31, 2020	BUY	$133.47 - $153.48 $800 - $920	6 Added 0.19%	3,113 $478,000
Q2 2019 Aug 07, 2019	BUY	$124.88 - $143.73 $388,002 - $446,569	3,107 New	3,107 $444,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Greenwood Gearhart Inc, based on Form 13F filings with the SEC.

Stay updated on Greenwood Gearhart Inc with notifications on news.